Melcher; Thorsten

Patent Applications and Registrations

Patent applications and USPTO patent grants for Melcher; Thorsten.The latest application filed is for "prevention and treatment of cognitive impairment using (r)-(-)-5-methyl-1-nicotynoyl-2-pyrazoline (mnp) and analogs".

Company Profile

0.7.13

Melcher; Thorsten - San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of protein biomolecular targets in the treatment and visualization of brain tumors Grant 7,060,275 - Mueller , et al. June 13, 2	2006-06-13
Prevention and treatment of cognitive impairment using (R)-(-)-5-methyl-1-nicotynoyl-2-pyrazoline (MNP) and analogs App 20060014801 - Gallagher; Michela ; et al.	2006-01-19
Monoclonal antibodies directed to receptor protein tyrosine phosphatase zeta App 20050260132 - Chin, Daniel ; et al.	2005-11-24
High-throughput transcriptome and functional validation analysis Grant 6,924,109 - Melcher , et al. August 2, 2	2005-08-02
Interaction of NMDA receptor with protein serine threonine phosphatases App 20050074831 - Jerecic, Jasna ; et al.	2005-04-07
Use of protein biomolecular targets in the treatment and visualization of brain tumors App 20050074400 - Mueller, Sabine ; et al.	2005-04-07
High-throughput transcriptome and functional validation analysis App 20050053936 - Melcher, Thorsten ; et al.	2005-03-10
High-throughput transcriptome and functional validation analysis Grant 6,841,351 - Gan , et al. January 11, 2	2005-01-11
Interaction of NMDA receptor with protein tyrosine phosphatase App 20040072275 - Kask, Kalev ; et al.	2004-04-15
Method of diagnosing ischemic stroke via UCP-2 detection Grant 6,670,138 - Gonzalez-Zulueta , et al. December 30, 2	2003-12-30
Diagnostic marker for neurological conditions Grant 6,660,483 - Kask , et al. December 9, 2	2003-12-09
Use of protein biomolecular targets in the treatment and visualization of brain tumors App 20030118585 - Muller, Sabine ; et al.	2003-06-26
Interaction of NMDA receptor with protein tyrosine phosphatase App 20030092071 - Jerecic, Jasna ; et al.	2003-05-15
High-throughput transcriptome and functional validation analysis App 20030082570 - Melcher, Thorsten ; et al.	2003-05-01
Methods for identifying a modulator of the interaction of NMDA receptor with protein tyrosine phosphatase L1 Grant 6,521,414 - Melcher , et al. February 18, 2	2003-02-18
High-throughput transcriptome and functional validation analysis App 20030027168 - Gan, Li ; et al.	2003-02-06
Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries App 20020172958 - Gonzalez-Zulueta, Mirella ; et al.	2002-11-21
Use Of Protein Tyrosine Phosphatase Zeta As A Biomolecular Target In The Treatment And Visualization Of Brain Tumors App 20020146370 - Mueller, Sabine ; et al.	2002-10-10
Use of protein tyrosine phosphatase zeta as a biomolecular target in the treatment and visualization of brain tumors Grant 6,455,026 - Mueller , et al. September 24, 2	2002-09-24
Interaction of NMDA receptor with protein tyrosine phosphatase App 20010049348 - Melcher, Thorsten ; et al.	2001-12-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.